Integer Holdings Corporation Welcomes New Leadership
Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical device contract development and manufacturing industry, recently announced that Payman Khales has assumed the position of President and Chief Executive Officer. This change comes as part of a structured leadership transition that was first revealed to the public earlier this year.
Transition of Leadership
Khales steps into this pivotal role following the retirement of Joseph Dziedzic, who has served with distinction as President and CEO for the past eight years. Dziedzic will continue to serve as an advisor, ensuring a seamless transition until March 31, 2026. His extensive experience has significantly shaped the company’s direction during his tenure, positioning Integer for further growth.
Khales' Vision for the Future
Since his arrival at Integer in 2018, Khales has demonstrated remarkable leadership capabilities, especially as the President of the Cardio & Vascular division. Under his guidance, this segment achieved substantial sales growth, effectively doubling its revenue within a seven-year period. His strategic approach has also enhanced service levels and profitability, establishing Integer as a trusted partner for medical device companies.
Khales on His New Role
Upon his appointment, Khales expressed his enthusiasm about the opportunities that lie ahead. He stated, "It is a privilege to step into the role of CEO at Integer. I am energized by the opportunities ahead as we continue to advance our strategy." His commitment to fostering innovation and collaboration with clients reflects a strong vision for the company’s future. He aims to deliver impactful medical technologies to improve patient care globally.
Prior Experience and Expertise
Before joining Integer, Payman Khales held senior management roles at CECO Environmental Corp. and Ingersoll Rand Company. His educational background includes an Executive MBA from Indiana University’s Kelley School of Business and a Bachelor of Science in Mechanical Engineering from École Polytechnique de Montréal. This blend of education and experience equips him to lead Integer into a new era of success.
About Integer Holdings Corporation
Integer Holdings Corporation is recognized as one of the largest medical device contract development and manufacturing organizations globally. The company serves vital markets, including cardiac rhythm management and neuromodulation. Integer is dedicated to enhancing patient lives by offering high-quality and innovative products. With a commitment to excellence, their brands include trusted names such as Greatbatch Medical and Lake Region Medical.
Investor and Media Relations
For inquiries, the following contacts are available: Investor Relations: Kristen Stewart at kristen.stewart@integer.net (Phone: 551.337.3973). Media Relations: Lauren Ban at lauren.ban@integer.net (Phone: 469.476.9615).
Frequently Asked Questions
What recent changes have occurred in the leadership at Integer Holdings?
Payman Khales has been appointed as the new CEO, succeeding Joseph Dziedzic, who is retiring.
What accomplishments did Khales achieve prior to becoming CEO?
Khales successfully led the Cardio & Vascular division, doubling sales over seven years and improving profitability.
What is the mission of Integer Holdings Corporation?
Integer aims to enhance patient lives through innovative medical device solutions and high-quality manufacturing services.
Who can be contacted for investor relations at Integer?
Kristen Stewart handles investor relations and can be reached at kristen.stewart@integer.net.
What educational background supports Khales’ new leadership role?
Khales holds an Executive MBA and a Bachelor’s degree in Mechanical Engineering, preparing him for impactful leadership.
